Lilly Bio-Medicines is the largest of Lilly’s five business areas in terms of sales and accounts for nearly half of Lilly’s mid-to-late stage pipeline assets. Unlike Lilly’s other business areas, such as Diabetes or Oncology that focus exclusively in one therapeutic area, our business is diversified. Bio-Medicines include the therapeutic areas of neuroscience, cardiovascular, urology, musculoskeletal and autoimmunity. Bio-Medicines is also home to Lilly’s global marketing organization and Lilly’s PRA (pricing, reimbursement, and access) function which are leading development of capabilities, solutions and tools to ensure that Lilly delivers unparalleled customer experiences.
Across our therapeutic areas and geographies, it is our commitment to the patients we serve that unites us as a global team, sharpens our focus on the needs of our customers, and strengthens our resolve to make a difference – for patients and for Lilly. Our singular vision is to develop life-changing medicines and deliver unparalleled customer experiences.
For any further specific healthcare related inquiries, please consult your healthcare professional.